| Pharmaceutical active ingredients: |
| Insulin Isophane Injection Human |
| Available forms, composition and doses of HumaJect NPH: |
| N / A |
| HumaJect NPH medical category: |
| Human:Insulin preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A10AC01 - Insulin Human |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Eli Lilly |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Hypurin Bovine Isophane | Insulin Isophane Injection Bovine | Wockhardt |
| Hypurin Isophane | Insulin Isophane Injection Bovine highly purified | Wockhardt; Aspen Pharmacare; CP-Pharma |
| Iolin NPH | Insulin Isophane Injection Bovine highly purified; Insulin Isophane Injection Porcine highly purified | Novo Nordisk |
| Isotard MC | Insulin Isophane Injection Bovine monocomponent | Novo Nordisk |
| Neuphane | Insulin Isophane Injection Bovine purified | GlaxoSmithKline |
| Humaplus NPH | Insulin Isophane Injection Human | Eli Lilly |
| Humulin NPH | Insulin Isophane Injection Human | Eli Lilly; Zuellig Pharma |
| Insulin Basal | Insulin Isophane Injection Human | B. Braun |
| Insulin Basal | Insulin Isophane Injection Human | Ratiopharm |
| Insulin Basal | Insulin Isophane Injection Human | Sanofi-Aventis |